SUMO-1 CRISPR Knockout and Activation Products (h)

Por um escritor misterioso

Last updated 16 novembro 2024

SUMO-1 CRISPR Knockout and Activation Products (h)

SUMO-1 CRISPR Knockout and Activation Plasmids (h) designed to edit, knockdown or upregulate human SUMO-1 gene expression

Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure

Activation of the PSA gene by ETV1. A, ETV1 or its 6xA mutant (300 ng)

CRISPR/Cas9-engineered mesenchymal stromal/stem cells and their extracellular vesicles: A new approach to overcoming cell therapy limitations - ScienceDirect

Alternative splicing of the SUMO1/2/3 transcripts affects cellular SUMOylation and produces functionally distinct SUMO protein isoforms

Cancers, Free Full-Text

Recombinant Anti-Sumo 1 antibody [Y299] - ChIP Grade KO Tested (ab32058)

SUMOylation of xeroderma pigmentosum group C protein regulates DNA damage recognition during nucleotide excision repair

SUMO-1 CRISPR Knockout and Activation Products (h)

A Chemical Toolbox for Labeling and Degrading Engineered Cas Proteins

IDO CRISPR Knockout and Activation Plasmids (m) designed to edit, knockdown or upregulate mouse IDO gene expression

IDO CRISPR Knockout and Activation Products (m)

CRISPR/Cas9-mediated genome editing of PML in human cell lines. (A) The

are ready to use gene editing systems designed to knockout or upregulate gene expression of human Bcr

Bcr CRISPR Knockout and Activation Products (h)

Recomendado para você